Quick Answer
KESTRA MEDICAL TECHNOLOGIES, LTD. reported Operating Income of -$106.38 million for fiscal year 2025.
KESTRA MEDICAL TECHNOLOGIES, LTD. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$106.38M | -25.1% |
| 2024 | -$85.06M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | -$34.77M | -68.8% | -9.5% |
| October 31, 2025 | -$31.75M | -66.0% | -10.0% |
| July 31, 2025 | -$28.88M | -56.7% | -40.2% |
| January 31, 2025 | -$20.60M | — | -7.7% |
| October 31, 2024 | -$19.13M | — | -3.8% |
| July 31, 2024 | -$18.43M | — | — |
- KESTRA MEDICAL TECHNOLOGIES, LTD. showed a decrease of -25.1% in Operating Income compared to the prior fiscal year.
- Over the 2024–2025 period, KESTRA MEDICAL TECHNOLOGIES, LTD.’s operating income has declined by 25.1% (from -$85.06 million to -$106.38 million).
- The most recent figure is from KESTRA MEDICAL TECHNOLOGIES, LTD.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: